Applied Therapeutics Reports Third Quarter 2025 Financial Results 

Stock Information for Colombier Acquisition Corp. II Class A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Colombier Acquisition Corp. II Class A

Halper Sadeh LLC Encourages ALEX, DXLG, APLT Shareholders to Contact the Firm to Discuss Their Rights
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--ALEX, DVS, DXLG, and APLT
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutics Announces Corporate Updates
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Applied Therapeutics Provides Update Following Meeting with FDA
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.